New mechanism of action RANKL-antibodies reduce bone loss
Kreutzkamp, B.
Medizinische Monatsschrift für Pharmazeuten 29(11): 425-426
2006
ISSN/ISBN: 0342-9601 PMID: 17131695 Document Number: 599167
Document emailed within 1 workday
Related Documents
Mizoguchi, T. 2011: RANKL signaling and bone diseases. Quiescent osteoclast precursors and RANKL signaling Clinical Calcium 21(8): 1187-1192Morimoto, Y. 1986: Metabolic bone diseases: various factors influencing bone resorption and osteogenesis--with special reference to the mechanism of action--steroid hormone Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2391-2398
Mikhaĭlov, V.V.; Gerina, L.S.; Neustroev, G.V.; Avakumov, V.M. 1987: Mechanism of the protective action of cobamamide and leucovorin on hematopoiesis in acute blood loss Farmakologiia i Toksikologiia 50(3): 92-94
Chailurkit, L-Or.; Piaseu, N.; Rajatanavin, R. 2002: Influence of normal ageing on mechanism of bone loss in women and men in Bangkok Journal of the Medical Association of Thailand 85(8): 915-921
Chailurkit, L.O.; Pongchaiyakul, C.; Charoenkiatkul, S.; Kosulwat, V.; Rojroongwasinkul, N.; Rajatanavin, R. 2001: Different mechanism of bone loss in ageing women and men in Khon Kaen Province Journal of the Medical Association of Thailand 84(8): 1175-1182
Udagawa, N.; Nakamura, M.; Takahashi, N. 2004: Possible role of RANKL in bone resorption Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 2): 97-101
Zhao, Y.; Cai, Y.; Wang, Y.-n. 2010: RANKL and OPG regulation on bone remodeling Shanghai Kou Qiang Yi Xue 19(4): 443-446
Chen, J.T.; Shiraki, M.; Katase, K.; Kato, T.; Hirai, Y.; Hasumi, K. 1994: Calcitonin physiologically regulates the postmenopausal bone loss and possibly inhibits the bone loss in fast losers Nihon Sanka Fujinka Gakkai Zasshi 46(10): 1056-1062
Min, M.; Zhang, Z. 2015: Mechanism of bone marrow mesenchymal stem cells in treatment of noise induced hearing loss with intravenous transplantation Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 50(1): 75-79
Wells, H.; Lloyd, W. 1970: Cyclic 3',5'-adenylic acid in bone and the mechanism of action of parathyroid hormone. Discussion Federation Proceedings 29(3): 1183-1184
Juji, T.; Tanaka, S. 2004: Novel therapeutic approach to bone metabolic disorders using RANKL vaccination Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 2): 799-802
Yoneda, T. 2011: Involvement of RANKL/RANK pathway in bone metastasis in breast cancer Clinical Calcium 21(8): 1159-1166
Yoneda, T. 2012: Treatment of bone metastasis by denosumab, the human monoclonal neutralizing antibody to RANKL Nihon Rinsho. Japanese Journal of Clinical Medicine 70(12): 2165-2171
Wen, H.; Liu, Y.; Li, J.; Wei, D.; Liu, D.; Zhao, F. 2018: Inhibitory effect and mechanism of 1,25-dihydroxy vitamin D3 on RANKL expression in fibroblast-like synoviocytes and osteoclast-like cell formation induced by IL-22 in rheumatoid arthritis Clinical and Experimental Rheumatology 36(5): 798-805
Garbossa, G.; Gutnisky, A.; Nesse, A. 1994: The inhibitory action of aluminum on mouse bone marrow cell growth: evidence for an erythropoietin- and transferrin-mediated mechanism Mineral and Electrolyte Metabolism 20(3): 141-146
Ciacli, C.; Puşchiţă, M. 2011: RANKL/RANK/OPG molecular complex--control factors in bone remodeling in psoriatic arthritis Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 115(2): 354-360
Xu, S.; Ma, X-Xi.; Hu, L-Wei.; Peng, L-Ping.; Pan, F-Ming.; Xu, J-Hua. 2014: Single nucleotide polymorphism of RANKL and OPG genes may play a role in bone and joint injury in rheumatoid arthritis Clinical and Experimental Rheumatology 32(5): 697-704
Kaneko, K.; Kawai, S. 2014: Glucocorticoid and Bone. Significance of serum soluble RANKL measurement in patients under glucocorticoid therapy Clinical Calcium 24(9): 1361-1370
Kwan Tat, S.; Pelletier, J.-P.; Lajeunesse, D.; Fahmi, H.; Lavigne, M.; Martel-Pelletier, J. 2008: The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells Clinical and Experimental Rheumatology 26(2): 295-304
Bimstein, E.; Garcia-Godoy, F. 1994: The significance of age, proximal caries, gingival inflammation, probing depths and the loss of lamina dura in the diagnosis of alveolar bone loss in the primary molars Asdc Journal of Dentistry for Children 61(2): 125-128